These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9847430)

  • 21. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge].
    Rubinsztajn R; Wrońska J; Chazan R
    Pol Arch Med Wewn; 2003 Aug; 110(2):849-54. PubMed ID: 14682223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects.
    Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH
    Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects.
    Christie PE; Tagari P; Ford-Hutchinson AW; Charlesson S; Chee P; Arm JP; Lee TH
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1025-9. PubMed ID: 1850964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of a specific COX-2 inhibitor in aspirin-induced asthma.
    Szczeklik A; Nizankowska E; Bochenek G; Nagraba K; Mejza F; Swierczynska M
    Clin Exp Allergy; 2001 Feb; 31(2):219-25. PubMed ID: 11251623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma.
    Nasser SM; Patel M; Bell GS; Lee TH
    Am J Respir Crit Care Med; 1995 May; 151(5):1326-30. PubMed ID: 7735581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-asthma effect of an antiviral drug, acyclovir: a clinical case and experimental study.
    Okada H; Ohnishi T; Hirashima M; Fujita J; Yamaji Y; Takahara J; Todani T
    Clin Exp Allergy; 1997 Apr; 27(4):431-7. PubMed ID: 9146937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.
    Wenzel SE; Trudeau JB; Kaminsky DA; Cohn J; Martin RJ; Westcott JY
    Am J Respir Crit Care Med; 1995 Sep; 152(3):897-905. PubMed ID: 7663802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects.
    Christie PE; Schmitz-Schumann M; Spur BW; Lee TH
    Eur Respir J; 1993 Nov; 6(10):1468-73. PubMed ID: 8112440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
    Mita H; Higashi N; Taniguchi M; Higashi A; Akiyama K
    Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078.
    Yamamoto H; Nagata M; Kuramitsu K; Tabe K; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
    Am J Respir Crit Care Med; 1994 Jul; 150(1):254-7. PubMed ID: 8025759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma.
    Vachier I; Kumlin M; Dahlén SE; Bousquet J; Godard P; Chanez P
    Respir Med; 2003 Nov; 97(11):1225-9. PubMed ID: 14635978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.
    Nizankowska E; Bestyńska-Krypel A; Cmiel A; Szczeklik A
    Eur Respir J; 2000 May; 15(5):863-9. PubMed ID: 10853850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of mast cell activation and leukotriene release after mannitol inhalation.
    Brannan JD; Gulliksson M; Anderson SD; Chew N; Kumlin M
    Eur Respir J; 2003 Sep; 22(3):491-6. PubMed ID: 14516140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of urinary leukotriene E4 levels in asymptomatic bronchial asthma].
    Yamamoto H; Kuramitsu K; Houya I; Maruo H; Sakata K; Tabe K; Kimura I; Inoue K; Shibasaki M; Yamamoto K; Sakamoto Y; Matsuo H
    Arerugi; 1996 Oct; 45(10):1106-11. PubMed ID: 8958657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma.
    Severien C; Artlich A; Jonas S; Becher G
    Eur Respir J; 2000 Oct; 16(4):588-92. PubMed ID: 11106196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
    Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
    [No Abstract]   [Full Text] [Related]  

  • 40. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.